Quantcast
Channel: New-York – EEI-BIOTECHFINANCES
Viewing all articles
Browse latest Browse all 1030

NeuroMetrix Announces Participation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 11-13th, 2016

$
0
0
Tuesday, September 6th 2016 at 3:00pm UTC

WALTHAM, Mass.–(BUSINESS WIRE)– NeuroMetrix, Inc. (NASDAQ:NURO) today announced it will be featured as a
presenting company at the 18th Annual Rodman & Renshaw Global
Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The
conference is being held on September 11-13, 2016, at Lotte New York
Palace Hotel in New York City.

Shai N. Gozani, M.D., Ph.D., President and CEO of NeuroMetrix, will
provide an overview of the Company’s business during the live
presentation and will be available to participate in one-on-one meetings
with investors who are registered to attend the conference.

NeuroMetrix’s presentation is scheduled for Monday, September 12, 2016
at 9:10 a.m. Eastern time.

A live audio webcast will be available on the investor relations section
of the corporate website, www.NeuroMetrix.com.
This webcast will be archived after the live event.

About NeuroMetrix

NeuroMetrix is a commercial stage, innovation driven healthcare company
combining bioelectrical and digital medicine to address chronic health
conditions including chronic pain, sleep disorders and diabetes. The
company’s lead product is Quell®, an over-the-counter
wearable therapeutic device for chronic pain. Quell is integrated into a
digital health platform that helps patients optimize their therapy and
decrease the impact of chronic pain on their quality of life. The
company also markets DPNCheck®, a rapid point-of-care test
for diabetic neuropathy, which is the most common long-term complication
of Type 2 diabetes. The company maintains an active research effort and
has several pipeline programs, including a therapeutic device for
restless leg syndrome. The company is located in Waltham,
Massachusetts and was founded as a spinoff from the Harvard-MIT Division
of Health Sciences and Technology in 1996. For more information, please
visit www.NeuroMetrix.com.

Contacts

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and
Chief Financial Officer
Neurometrix.ir@neurometrix.com

Source: NeuroMetrix, Inc.

Cet article NeuroMetrix Announces Participation at the 18th
Annual Rodman & Renshaw Global Investment Conference in New York City
September 11-13th, 2016
est apparu en premier sur EEI-BIOTECHFINANCES.


Viewing all articles
Browse latest Browse all 1030

Trending Articles